EMBC Stock Price, Chart, Stats & News

Embecta Corp.
Save
EMBC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.73% |
Operating margin | 32.06% |
Pretax margin | 18.14% |
Net margin | 12.92% |
Effective tax rate | 28.79% |
ROA | 13.11% |
ROE | -20.90% |
D/E | -2.32x |
Interest coverage ratio | 3.34x |
EMBC valuation
P/E | 1.65x |
P/S | 0.47x |
P/B | -0.82x |
P/CF | 2.33x |
P/FCF | 2.47x |
P/OCF | 2.33x |
PEG | 0.08x |
EV multiple | -2.01x |
About
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition.
Similar securities
Based on sector and market capitalization
Report issue











